These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33295607)

  • 21. Serum protease activity in chronic kidney disease patients: The GANI_MED renal cohort.
    Wolke C; Teumer A; Endlich K; Endlich N; Rettig R; Stracke S; Fiene B; Aymanns S; Felix SB; Hannemann A; Lendeckel U
    Exp Biol Med (Maywood); 2017 Mar; 242(5):554-563. PubMed ID: 28038565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered circulating concentrations of active glucagon-like peptide (GLP-1) and dipeptidyl peptidase 4 (DPP4) in obese subjects and their association with insulin resistance.
    Ahmed RH; Huri HZ; Muniandy S; Al-Hamodi Z; Al-Absi B; Alsalahi A; Razif MF
    Clin Biochem; 2017 Sep; 50(13-14):746-749. PubMed ID: 28288852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dipeptidyl peptidase-4 inhibition: insights from the bench and recent clinical studies.
    Zhong J; Kankanala S; Rajagopalan S
    Curr Opin Lipidol; 2016 Oct; 27(5):484-92. PubMed ID: 27472408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension.
    Cappetta D; Ciuffreda LP; Cozzolino A; Esposito G; Scavone C; Sapio L; Naviglio S; D'Amario D; Crea F; Rossi F; Berrino L; De Angelis A; Urbanek K
    Oxid Med Cell Longev; 2019; 2019():8912768. PubMed ID: 30774748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice.
    Yazbeck R; Howarth GS; Geier MS; Demuth HU; Abbott CA
    Front Biosci; 2008 May; 13():6850-8. PubMed ID: 18508699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.
    Jackson EK; Mi Z; Tofovic SP; Gillespie DG
    Hypertension; 2015 Jan; 65(1):238-49. PubMed ID: 25368027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of Diet and Gender on Plasma DPP4 Activity and GLP-1 in Patients with Metabolic Syndrome: An Experimental Pilot Study.
    Pérez-Durillo FT; Segarra AB; Villarejo AB; Ramírez-Sánchez M; Prieto I
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29958403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth factor based therapies and intestinal disease: is glucagon-like peptide-2 the new way forward?
    Yazbeck R; Howarth GS; Abbott CA
    Cytokine Growth Factor Rev; 2009 Apr; 20(2):175-84. PubMed ID: 19324585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dipeptidyl-peptidase 4 inhibition and the vascular effects of glucagon-like peptide-1 and brain natriuretic peptide in the human forearm.
    Devin JK; Pretorius M; Nian H; Yu C; Billings FT; Brown NJ
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25158865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased liver damage in rat models of short bowel syndrome through DPP4 inhibition.
    Sueyoshi R; Furuhashi N; Ishii J; Yamaguchi R; Kawakami M; Tanabe K; Segawa O
    Pediatr Surg Int; 2022 Nov; 39(1):21. PubMed ID: 36449115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury.
    Ihara M; Asanuma H; Yamazaki S; Kato H; Asano Y; Shinozaki Y; Mori H; Minamino T; Asakura M; Sugimachi M; Mochizuki N; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1287-97. PubMed ID: 25747753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance.
    Itou M; Kawaguchi T; Taniguchi E; Sumie S; Oriishi T; Mitsuyama K; Tsuruta O; Ueno T; Sata M
    J Gastroenterol Hepatol; 2008 Feb; 23(2):244-51. PubMed ID: 17944883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma DPP4 Activities Are Associated With Osteoporosis in Postmenopausal Women With Normal Glucose Tolerance.
    Zheng T; Yang L; Liu Y; Liu H; Yu J; Zhang X; Qin S
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3862-70. PubMed ID: 26259132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors.
    Mulvihill EE; Drucker DJ
    Endocr Rev; 2014 Dec; 35(6):992-1019. PubMed ID: 25216328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of glucagon-like peptides in inflammatory bowel diseases-current knowledge and future perspectives.
    Zatorski H; Sałaga M; Fichna J
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1321-1330. PubMed ID: 31359088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.
    Mulvihill EE; Varin EM; Gladanac B; Campbell JE; Ussher JR; Baggio LL; Yusta B; Ayala J; Burmeister MA; Matthews D; Bang KWA; Ayala JE; Drucker DJ
    Cell Metab; 2017 Jan; 25(1):152-165. PubMed ID: 27839908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GLP-1 signaling preserves cardiac function in endotoxemic Fischer 344 and DPP4-deficient rats.
    Ku HC; Chen WP; Su MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec; 382(5-6):463-74. PubMed ID: 20852989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 receptor agonists on cognitive functions in adults with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Jin Y; Zhao H; Hou Y; Song G
    Acta Diabetol; 2020 Oct; 57(10):1129-1144. PubMed ID: 32300876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cord serum dipeptidyl-peptidase 4 activity in gestational diabetes.
    Al-Aissa Z; Rosta K; Hadarits O; Harreiter J; Zóka A; Bancher-Todesca D; Patócs A; Kiss K; Sármán B; Pusztai P; Sziller I; Rigó J; Rácz K; Somogyi A; Kautzky-Willer A; Firneisz G
    Eur J Clin Invest; 2015 Feb; 45(2):196-203. PubMed ID: 25556541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of DPP4 activity in cardiovascular districts: in vivo and in vitro evidence.
    Pala L; Rotella CM
    J Diabetes Res; 2013; 2013():590456. PubMed ID: 23853775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.